Mehrdad Kevin Ariani

Mehrdad Ariani practices at Northridge Hospital Medical Center in Northridge, California.

Mehrdad Ariani's NPI, 1942496211, was assigned on September 20, 2007. Mehrdad Ariani graduated from Tehran University of Medical Sciences School of Medicine in 1984. Mehrdad Ariani holds California license A48708.

Mehrdad Ariani's primary practice is Northridge Hospital Medical Center, at 18350 W Roscoe Blvd, Northridge, CA 91325 in Los Angeles County. The practice phone is (818) 993-9824.

Mehrdad Ariani's primary practice is Northridge Hospital Medical Center in Northridge, California. Mehrdad Ariani is also affiliated with Dignity Health - Northridge Hospital Medical Center. The medical group on file is Valley Vascular Partners. Dmand AI also links Mehrdad Ariani to 2 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mehrdad Ariani practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Mehrdad Ariani's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Mehrdad Ariani is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Mehrdad Ariani's licenses on file in 3 states: California, North Carolina and Texas.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic hypertension and coronary artery disease among the conditions Mehrdad Ariani treats.

CMS data shows 7,541 Medicare services from Mehrdad Ariani across 47 procedure codes in 2024, for 1,187 Medicare patients. Medicare paid $884,242 for them.

CMS counts 1,187 Medicare patients who saw Mehrdad Ariani in 2024. The largest group is 75 to 84, with 437 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 59% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mehrdad Ariani's median patient age at 75, with 47% women.

In 2024, Mehrdad Ariani wrote 9,331 Medicare Part D claims for 896 patients. 74% of them were for generic drugs. CMS names the drug for 8,822 of them, across 111 drugs with 11 or more claims each, at $1,926,906 in total drug cost. In 2023, CMS named 9,266 claims across 122 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Mehrdad Ariani for performance year 2024, reported individually. Mehrdad Ariani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mehrdad Ariani as offering telehealth. CMS counts 83 procedures of coronary angioplasty and stenting by Mehrdad Ariani, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Mehrdad Ariani. Mehrdad Ariani's most frequent co-authors are Robert J. Siegel, MD, Byron J J. Allen, MD and Peng-Sheng Chen, MD.

Dmand AI links Mehrdad Ariani to 6 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Heart Failure, Atrial Fibrillation and Heart Failure, Diastolic. Open Payments lists research payments to Mehrdad Ariani that name 2 trials.

CMS Open Payments shows 1,913 general payments to Mehrdad Ariani from 71 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Amgen Inc. paid the most, $51,708. It also lists 10 research payments totaling $70,634 from 2021 to 2024, naming 2 clinical trials.

Dmand AI lists 3 awards for Mehrdad Ariani, most recently ACP Fellow in 2012.

Mehrdad Ariani graduated from Tehran University of Medical Sciences School of Medicine in 1984. Mehrdad Ariani is a member of ACC and ACP.

Mehrdad Ariani is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.